NLT SPINE Secures Additional Funding Of $5.7 million
NLT SPINE, a developer of Minimally Invasive Spine Surgery (MISS) products, announced it has secured additional funding from existing investors, Accelmed and Peregrine Ventures. The investment of $5.7 million will be used to fuel the development of its PROW LIF line for the treatment of degenerative spinal conditions, as well as expand its presence in […]
March 07, 2012